Literature DB >> 18253748

Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion.

Laurence Bianchini1, Georges Maire, Bernard Guillot, Jean-Marie Joujoux, Philippe Follana, Marie-Pierre Simon, Jean-Michel Coindre, Florence Pedeutour.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare, dermal neoplasm of intermediate malignancy. It is made of spindle-shaped tumor cells in a storiform pattern positive for CD34. Cytogenetically, DFSP cells are characterized by either supernumerary ring chromosomes composed of sequences derived from chromosomes 17 and 22 or more rarely of translocations t(17;22). These chromosomal rearrangements lead to the formation of a specific chimeric gene fusing COL1A1 to PDGFB. So far, the COL1A1-PDGFB fusion gene remains the sole fusion gene identified in DFSP. However, some observations suggest that genes, other than COL1A1 and PDGFB, might be involved in some DFSP cases. We report in this paper a DFSP case presenting as a unique chromosomal abnormality a complex translocation between chromosomes 5 and 8. This is the first report of a DFSP case where the lack of chromosomes 17 and 22 rearrangement and the absence of COL1A1-PDGFB fusion gene have been demonstrated. Using fluorescence in situ hybridization analysis, we showed that the CSPG2 gene at 5q14.3 and the PTK2B gene at 8p21.2 were disrupted by this rearrangement. Although rare, the existence of cases of DFSP negative for the COL1A1-PDGFB fusion has to be taken in consideration when performing molecular diagnosis for a tumor suspected to be a DFSP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253748     DOI: 10.1007/s00428-008-0580-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  40 in total

1.  The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells.

Authors:  Sabrina Cattaruzza; Monica Schiappacassi; Koji Kimata; Alfonso Colombatti; Roberto Perris
Journal:  FASEB J       Date:  2004-02-20       Impact factor: 5.191

2.  Isolation and characterization of human orthologs of yeast CCR4-NOT complex subunits.

Authors:  T K Albert; M Lemaire; N L van Berkum; R Gentz; M A Collart; H T Timmers
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

3.  Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer.

Authors:  C Ricciardelli; K Mayne; P J Sykes; W A Raymond; K McCaul; V R Marshall; D J Horsfall
Journal:  Clin Cancer Res       Date:  1998-04       Impact factor: 12.531

4.  Translocation (2;17) in recurrent dermatofibrosarcoma protuberans.

Authors:  J Sinovic; J A Bridge
Journal:  Cancer Genet Cytogenet       Date:  1994-07-15

5.  Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors.

Authors:  J Limon; P Dal Cin; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1986-12

6.  Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma.

Authors:  M P Simon; F Pedeutour; N Sirvent; J Grosgeorge; F Minoletti; J M Coindre; M J Terrier-Lacombe; N Mandahl; R D Craver; N Blin; G Sozzi; C Turc-Carel; K P O'Brien; D Kedra; I Fransson; C Guilbaud; J P Dumanski
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

7.  A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans.

Authors:  Georges Maire; Sylvie Fraitag; Louise Galmiche; Frédérique Keslair; Nathalie Ebran; Marie-José Terrier-Lacombe; Yves de Prost; Florence Pedeutour
Journal:  Arch Dermatol       Date:  2007-02

8.  [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].

Authors:  Laurence Bianchini; Georges Maire; Florence Pedeutour
Journal:  Bull Cancer       Date:  2007-02       Impact factor: 1.276

Review 9.  The impact of translocations and gene fusions on cancer causation.

Authors:  Felix Mitelman; Bertil Johansson; Fredrik Mertens
Journal:  Nat Rev Cancer       Date:  2007-03-15       Impact factor: 60.716

10.  Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.

Authors:  Marie-Josée Terrier-Lacombe; Louis Guillou; Georges Maire; Philippe Terrier; Dominique Ranchère Vince; Nicolas de Saint Aubain Somerhausen; Françoise Collin; Florence Pedeutour; Jean-Michel Coindre
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

View more
  6 in total

1.  Coamplification of 12q15 and 12p13 and homozygous CDKN2A/2B deletion: synergistic role of fibrosarcomatous transformation in dermatofibrosarcoma protuberans with a cryptic COL1A1-PDGFB fusion.

Authors:  Yang Lu; Tao Li; Min Chen; Heng Peng; Tianhai Du; Yan Qiu; Hongying Zhang
Journal:  Virchows Arch       Date:  2022-02-16       Impact factor: 4.535

2.  Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans.

Authors:  Marie Karanian; Gaëlle Pérot; Jean-Michel Coindre; Frédéric Chibon; Florence Pedeutour; Agnès Neuville
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

3.  Rapid Growth of Dermatofibrosarcoma Protuberans Associated with Bilateral Adrenalectomy for Cushing's Syndrome.

Authors:  Sadanori Furudate; Taku Fujimura; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2011-05-20

4.  Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.

Authors:  Cong Peng; Xingxing Jian; Yang Xie; Lingfeng Li; Jian Ouyang; Ling Tang; Xu Zhang; Juan Su; Shuang Zhao; Hong Liu; Mingzhu Yin; Dan Wu; Miaojian Wan; Lu Xie; Xiang Chen
Journal:  Br J Dermatol       Date:  2022-04-19       Impact factor: 11.113

5.  Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masatoshi Naito
Journal:  Genet Res Int       Date:  2011-07-28

Review 6.  Dermatofibrosarcoma protuberans: from translocation to targeted therapy.

Authors:  Jonathan Noujaim; Khin Thway; Cyril Fisher; Robin L Jones
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.